Skip to main content
    Z

    Zenas BioPharma, Inc. Common Stock (ZBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $27.93
    -0.08 (-0.29%)

    Market Cap: $1.90B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Zenas BioPharma, Inc. Common Stock (ZBIO) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Zenas BioPharma, Inc. Common Stock (ZBIO) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, Zenas BioPharma, Inc. Common Stock reported EPS of -$1.65, below the -$1.20 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    30%(3/10)
    Avg Surprise
    -28.17%

    Upcoming Estimates

    Reports Mar 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$1.34
    Range-$1.34 - -$1.28
    8 analysts
    Revenue Consensus
    N/A
    RangeN/A
    6 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$1.42
    Range-$1.45 - -$1.39
    3 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$1.14-24.3%
    60d ago-$1.37-3.4%
    30d ago-$1.37-3.4%
    7d ago-$1.37-3.4%
    Current-$1.42
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    ZBIO has an expected report date of Mar 15, 2027.

    Earnings History

    Of the 10 quarters below that had an estimate, ZBIO beat 3 and missed 7. The widest gap in the table came in the quarter ended Jun 30, 2024, when EPS landed 125.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$1.65-$1.20N/A-37.50%MissN/A21 up, 1 downNov 5, 2026$10.00M
    Jun 30, 2026-$1.77-$0.89-$1.46 - -$0.05-98.88%MissN/A2N/AAug 12, 2026$1.00M
    Mar 31, 2026-$1.46-$1.54-$1.54 - -$1.54+5.19%BeatN/A10 up, 0 downMay 13, 2026N/A
    Dec 31, 2025-$1.39-$1.19N/A-16.81%MissN/A10 up, 1 downMar 16, 2026$10.00M
    Sep 30, 2025-$1.22-$0.85-$1.21 - -$0.21-43.53%MissN/A30 up, 1 downNov 12, 2025N/A
    Jun 30, 2025-$1.25-$1.06N/A-17.92%MissN/A11 up, 0 downAug 12, 2025N/A
    Mar 31, 2025-$0.80-$1.15N/A+30.43%BeatN/AN/AN/AMay 15, 2025$10.00M
    Dec 31, 2024-$1.26-$1.02N/A-23.69%MissN/AN/AN/AMar 25, 2025$5.00M
    Sep 30, 2024-$5.02-$9.30N/A+46.02%BeatN/AN/AN/ANov 12, 2024N/A
    Jun 30, 2024-$2.79-$1.24N/A-125.00%MissN/AN/AN/AAug 22, 2024N/A
    Last 10 quarters

    Annual EPS

    Fiscal year endedEPSChange
    Sep 30, 2026-$4.88N/A
    Jun 30, 2026-$3.23N/A
    Dec 31, 2025-$4.66N/A
    Dec 31, 2024-$9.07N/A

    Frequently Asked Questions About ZBIO

    When is Zenas BioPharma, Inc. Common Stock's next earnings date?

    Zenas BioPharma, Inc. Common Stock's next earnings report is expected for Mar 15, 2027.

    Did ZBIO beat earnings estimates last quarter?

    No. Zenas BioPharma, Inc. Common Stock reported EPS of -$1.65 for the quarter ended Sep 30, 2026, below the -$1.20 estimate by 37.50%.

    What EPS do analysts expect from ZBIO next quarter?

    The consensus EPS estimate for Zenas BioPharma, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$1.34 from 8 analysts, with estimates from -$1.34 to -$1.28.

    How often does ZBIO beat earnings estimates?

    Zenas BioPharma, Inc. Common Stock beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -25.34%.